Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.5.2 is now shown on the page; the previous label v3.5.0 has been removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.5.0 is listed as the current version, replacing v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing v3.4.1. No study content or page functionality appears to be affected.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page adds Revision: v3.4.1 and removes the earlier entries Revision: v3.4.0 and the government funding/operating-status notice.SummaryDifference0.4%

- Check82 days agoChange DetectedA government funding lapse notice has been added at the top of the page, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov for status updates.SummaryDifference0.4%

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.